These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10868502)

  • 21. Olanzapine-associated priapism.
    Gordon M; de Groot CM
    J Clin Psychopharmacol; 1999 Apr; 19(2):192. PubMed ID: 10211928
    [No Abstract]   [Full Text] [Related]  

  • 22. Olanzapine for the treatment of psychosis in patients with Parkinson's disease and dementia.
    Marsh L; Lyketsos C; Reich SG
    Psychosomatics; 2001; 42(6):477-81. PubMed ID: 11815682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Olanzapine-induced agranulocytosis: a case report and review of the literature.
    Tolosa-Vilella C; Ruiz-Ripoll A; Mari-Alfonso B; Naval-Sendra E
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Feb; 26(2):411-4. PubMed ID: 11817522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Neuroleptic malignant syndrome and atypical antipsychotics].
    Canora Lebrato J; Bermúdez García JM; Alvarez García ML; Rico Irles J
    Med Clin (Barc); 2000 Sep; 115(7):279. PubMed ID: 11013157
    [No Abstract]   [Full Text] [Related]  

  • 25. Olanzapine and rhabdomyolysis.
    Shuster J
    Nursing; 2000 Sep; 30(9):87. PubMed ID: 11022553
    [No Abstract]   [Full Text] [Related]  

  • 26. Olanzapine and tardive dyskinesia.
    Woods SW
    Br J Psychiatry; 1999 Oct; 175():391-2. PubMed ID: 10789313
    [No Abstract]   [Full Text] [Related]  

  • 27. Olanzapine: weight gain and therapeutic efficacy.
    Gupta S; Droney T; Al-Samarrai S; Keller P; Frank B
    J Clin Psychopharmacol; 1999 Jun; 19(3):273-5. PubMed ID: 10350036
    [No Abstract]   [Full Text] [Related]  

  • 28. Olanzepine-induced tardive dyskinesia.
    Bella VL; Piccoli F
    Br J Psychiatry; 2003 Jan; 182():81-2. PubMed ID: 12509329
    [No Abstract]   [Full Text] [Related]  

  • 29. Uncommon side effects associated with olanzapine. A case report.
    Farooque R
    Pharmacopsychiatry; 2003; 36(2):83. PubMed ID: 12734767
    [No Abstract]   [Full Text] [Related]  

  • 30. Efficacy should drive atypical antipsychotic treatment.
    Citrome LL
    BMJ; 2003 Feb; 326(7383):283. PubMed ID: 12561827
    [No Abstract]   [Full Text] [Related]  

  • 31. Pustular eruption induced by olanzapine, a novel antipsychotic agent.
    Adams BB; Mutasim DF
    J Am Acad Dermatol; 1999 Nov; 41(5 Pt 2):851-3. PubMed ID: 10534668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atypical antipsychotic drugs and hyperglycemia in adolescents.
    Koller E; Malozowski S; Doraiswamy PM
    JAMA; 2001 Nov; 286(20):2547-8. PubMed ID: 11722267
    [No Abstract]   [Full Text] [Related]  

  • 33. Possible neuroleptic malignant syndrome associated with olanzapine.
    Nyfort-Hansen K; Alderman CP
    Ann Pharmacother; 2000 May; 34(5):667. PubMed ID: 10852098
    [No Abstract]   [Full Text] [Related]  

  • 34. Olanzapine motor side effect.
    Daniel DG; Egan M; Issa F
    Neuropsychopharmacology; 1997 Jan; 16(1):88-90. PubMed ID: 8981393
    [No Abstract]   [Full Text] [Related]  

  • 35. Olanzapine-induced bilateral pedal edema: a case report.
    Yovtcheva SP; Yazel JJ
    Gen Hosp Psychiatry; 2000; 22(4):290-1. PubMed ID: 11023366
    [No Abstract]   [Full Text] [Related]  

  • 36. Repeated episodes of hypothermia in a subject treated with haloperidol, levomepromazine, olanzapine, and thioridazine.
    Hägg S; Mjörndal T; Lindqvist L
    J Clin Psychopharmacol; 2001 Feb; 21(1):113-5. PubMed ID: 11199936
    [No Abstract]   [Full Text] [Related]  

  • 37. Olanzapine-associated priapism.
    Childers JB; Schwartz AC; Compton MT
    Psychosomatics; 2003; 44(4):351-2. PubMed ID: 12832606
    [No Abstract]   [Full Text] [Related]  

  • 38. Olanzapine and venous thromboembolism.
    Hägg S; Tätting P; Spigset O
    Int Clin Psychopharmacol; 2003 Sep; 18(5):299-300. PubMed ID: 12920392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroleptic malignant syndrome and low-dose olanzapine.
    Suh H; Bronson B; Martin R
    Am J Psychiatry; 2003 Apr; 160(4):796. PubMed ID: 12668376
    [No Abstract]   [Full Text] [Related]  

  • 40. Olanzapine-induced neuroleptic malignant syndrome.
    Burkhard PR; Vingerhoets FJ; Alberque C; Landis T
    Arch Gen Psychiatry; 1999 Jan; 56(1):101-2. PubMed ID: 9892264
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.